Status:
UNKNOWN
Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias
Lead Sponsor:
Erasmus Medical Center
Conditions:
Tachycardia; Paroxysmal, Supraventricular
Tachycardia, Supraventricular
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this single-center prospective randomized controlled trial is to assess the superiority of contact-force-(CF)-sensing-based approach compared to conventional (non-CF-sensing) approach in th...
Detailed Description
Rationale: Multiple studies have demonstrated the importance of adequate catheter-tissue contact in the creation of effective lesions during radiofrequency catheter ablation. The development of conta...
Eligibility Criteria
Inclusion
- Referral for electrophysiology study because of pre-excitation on 12-lead surface ECG and/or documented (or suspected) symptomatic PSVT
- Identification of AVNRT or WPW-AVRT (with manifest or concealed accessory pathway) during standard EP study
- Verbal consent to continue with ablation therapy
- Informed written consent to be included in the study
Exclusion
- evidence of structural heart disease and/or myocardial ischemia
- pregnancy (and lack of exclusion of potential pregnancy)
- age below 18 years
Key Trial Info
Start Date :
June 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2021
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT04078685
Start Date
June 12 2018
End Date
March 20 2021
Last Update
September 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC
Rotterdam, Netherlands, 3015 GD